Filing Details

Accession Number:
0001179110-17-012721
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-26 17:47:07
Reporting Period:
2017-09-22
Accepted Time:
2017-09-26 17:47:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587070 Jaime Contreras 100 Abbott Park Road
Abbott Park IL 60064
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2017-09-22 13,400 $26.19 58,739 No 4 M Direct
Common Shares Without Par Value Acquisiton 2017-09-22 17,300 $22.39 76,039 No 4 M Direct
Common Shares Without Par Value Acquisiton 2017-09-22 22,000 $27.03 98,039 No 4 M Direct
Common Shares Without Par Value Disposition 2017-09-22 34,400 $51.95 63,639 No 4 S Direct
Common Shares Without Par Value Disposition 2017-09-22 4,152 $51.96 59,487 No 4 S Direct
Common Shares Without Par Value Disposition 2017-09-22 1,701 $51.97 57,786 No 4 S Direct
Common Shares Without Par Value Disposition 2017-09-22 1,913 $51.98 55,873 No 4 S Direct
Common Shares Without Par Value Disposition 2017-09-22 909 $51.99 54,964 No 4 S Direct
Common Shares Without Par Value Disposition 2017-09-22 1,109 $52.00 53,855 No 4 S Direct
Common Shares Without Par Value Disposition 2017-09-22 3,816 $52.01 50,039 No 4 S Direct
Common Shares Without Par Value Disposition 2017-09-22 1,600 $52.02 48,439 No 4 S Direct
Common Shares Without Par Value Disposition 2017-09-22 200 $52.03 48,239 No 4 S Direct
Common Shares Without Par Value Disposition 2017-09-22 500 $52.03 47,739 No 4 S Direct
Common Shares Without Par Value Disposition 2017-09-22 1,200 $52.04 46,539 No 4 S Direct
Common Shares Without Par Value Disposition 2017-09-22 1,200 $52.04 45,339 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2017-09-22 13,400 $0.00 13,400 $26.19
Common Shares Option (right to buy) Disposition 2017-09-22 17,300 $0.00 17,300 $22.39
Common Shares Option (right to buy) Disposition 2017-09-22 22,000 $0.00 22,000 $27.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-02-19 2020-02-18 No 4 M Direct
0 2014-02-18 2021-02-17 No 4 M Direct
0 2015-02-17 2022-02-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares Without Par Value 21 Indirect Profit Sharing Trust
Common Shares Without Par Value 64,297 Indirect Jaime Contreras Marvan 2006 Living Trust
Common Shares Without Par Value 2,410 Indirect By Spouse
Common Shares Without Par Value 12,081 Indirect Living Trust (by spouse)
Footnotes
  1. Balance in the Abbott Laboratories Stock Retirement Trust as of September 22, 2017.
  2. Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
  3. The reporting person disclaims beneficial ownership of all securities held by his spouse.
  4. Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
  5. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.